European agency approves swine flu vaccines for licensingBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b3992 (Published 29 September 2009) Cite this as: BMJ 2009;339:b3992
- Sophie Cook
Two swine flu vaccines, including one of those to be used in the United Kingdom’s vaccination programme, were approved for licensing by the European Medicines Agency on 25 September.
The agency’s committee for medicinal products for human use expedited the assessment of the vaccines—Focetria from Novartis and Pandemrix from GlaxoSmithKline—and recommended that they be granted a licence by the European Commission.
The Department of Health for England said, “This is a positive step towards getting full licences for vaccines to protect the public. The European Commission must now consider the recommendations, and we hope for its decision as quickly …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial